Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study to Assess the Effect of AZD0780 on Ambulatory Blood Pressure

ClinicalTrials.gov ID: NCT06692764

Public ClinicalTrials.gov record NCT06692764. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 10:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Study to Assess the Effect of AZD0780 on Ambulatory Blood Pressure in Participants With Atherosclerotic Cardiovascular Disease or Risk Equivalents and Elevated Low-Density Lipoprotein Cholesterol

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase II, multi-centre, randomized, double-blind, placebo-controlled, crossover study to evaluate the effect of AZD0780 Dose 1 versus placebo on systolic blood pressure (SBP) at Week 4, as measured by 24-hour ambulatory blood pressure monitoring (ABPM) in participants with ASCVD or risk equivalents and LDL-C ≥ 70 mg/dL, on stable medication.

Study identification

NCT ID
NCT06692764
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AstraZeneca
Industry
Enrollment
202 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 30, 2024 (Actual)
Primary completion
Apr 18, 2025 (Actual)
Completion
May 2, 2025 (Actual)
Last update posted
Feb 18, 2026

2024 – 2025

United States locations

U.S. sites
26
U.S. states
10
U.S. cities
23
Facility City State ZIP Site status
Research Site Inglewood California 90301 —
Research Site Northridge California 91325 —
Research Site Pomona California 91767 —
Research Site Boca Raton Florida 33434 —
Research Site Hialeah Florida 33012 —
Research Site Jacksonville Florida 32216 —
Research Site Miami Florida 33122 —
Research Site Miami Florida 33165 —
Research Site Miami Florida 33173 —
Research Site Miami Florida 33174 —
Research Site Ocala Florida 34474 —
Research Site Port Orange Florida 32127 —
Research Site Tamarac Florida 33321 —
Research Site Chicago Illinois 60621 —
Research Site Potomac Maryland 20854 —
Research Site New Bedford Massachusetts 02740 —
Research Site New Windsor New York 12553 —
Research Site Beavercreek Ohio 45431 —
Research Site Horsham Pennsylvania 19044 —
Research Site Spartanburg South Carolina 29303 —
Research Site Austin Texas 78704 —
Research Site Dallas Texas 75230 —
Research Site El Paso Texas 79905 —
Research Site Hurst Texas 76054 —
Research Site Mesquite Texas 75149 —
Research Site Paris Texas 75462 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06692764, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 18, 2026 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06692764 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →